Title:
DRUG AND METHOD FOR TREATING OR PREVENTING KIDNEY DISEASE USING SAID DRUG
Document Type and Number:
WIPO Patent Application WO/2019/181388
Kind Code:
A1
Abstract:
A drug containing a compound represented by formula (I) as an active ingredient, used for kidney disease.
Inventors:
HASHIMOTO TERUMASA (JP)
SHIBATA KEITA (JP)
HONDA KAZUO (JP)
NOBE KOJI (JP)
SHIBATA KEITA (JP)
HONDA KAZUO (JP)
NOBE KOJI (JP)
Application Number:
PCT/JP2019/007339
Publication Date:
September 26, 2019
Filing Date:
February 26, 2019
Export Citation:
Assignee:
UNIV SHOWA (JP)
TMS CO LTD (JP)
TMS CO LTD (JP)
International Classes:
A61K31/407; A61K31/502; A61K47/55; A61P13/12
Domestic Patent References:
| WO2007040082A1 | 2007-04-12 | |||
| WO2007111203A1 | 2007-10-04 | |||
| WO2007040082A1 | 2007-04-12 |
Foreign References:
| JP2004224737A | 2004-08-12 | |||
| JP2004224738A | 2004-08-12 | |||
| JP2018057055A | 2018-04-05 |
Other References:
KEMMOCHI, SAYAKA ET AL.: "Protective effect of stachybotrys microspora triprenyl phenol-7 on the deposition of IgA to the glomerular mesangium in nivalenol-induced IgA nephropathy using BALB/c Mice", JOUNAL OF TOXICOLOGIC PATHOLOGY, vol. 25, no. 2, 2012, pages 149 - 154, XP055641110, ISSN: 0914-9168
SHIBATA, KEITA ET AL.: "Evaluation of the effects of a new series of SMTPs in the acetic acid- induced embolic cerebral infarct mouse model", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 818, 28 October 2017 (2017-10-28), pages 221 - 227, XP085313014, ISSN: 0014-2999, DOI: 10.1016/j.ejphar.2017.10.055
KODAMA, AZUSA ET AL.: "Albumin fusion renders thioredoxin an effective anti-oxidative and anti- inflammatory agent for preventing cisplatin- induced nephrotoxicity", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1840, no. 3, 2014, pages 1152 - 1162, XP028817260, ISSN: 0304-4165, DOI: 10.1016/j.bbagen.2013.12.007
TUZCU, M. ET AL.: "Protective role of zinc picolinate on cisplatin-induced nephrotoxicity in rats", JOURNAL OF RENAL NUTRITION, vol. 20, no. 6, 2010, pages 398 - 407, XP055641112, ISSN: 1051-2276
JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, vol. 87, no. 7, 1998, pages 1234 - 1240
FEBS LETTER, vol. 418, 1997, pages 58 - 62
J BIOL CHEM, vol. 289, 2014, pages 35826 - 35838
See also references of EP 3769762A4
SHIBATA, KEITA ET AL.: "Evaluation of the effects of a new series of SMTPs in the acetic acid- induced embolic cerebral infarct mouse model", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 818, 28 October 2017 (2017-10-28), pages 221 - 227, XP085313014, ISSN: 0014-2999, DOI: 10.1016/j.ejphar.2017.10.055
KODAMA, AZUSA ET AL.: "Albumin fusion renders thioredoxin an effective anti-oxidative and anti- inflammatory agent for preventing cisplatin- induced nephrotoxicity", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1840, no. 3, 2014, pages 1152 - 1162, XP028817260, ISSN: 0304-4165, DOI: 10.1016/j.bbagen.2013.12.007
TUZCU, M. ET AL.: "Protective role of zinc picolinate on cisplatin-induced nephrotoxicity in rats", JOURNAL OF RENAL NUTRITION, vol. 20, no. 6, 2010, pages 398 - 407, XP055641112, ISSN: 1051-2276
JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, vol. 87, no. 7, 1998, pages 1234 - 1240
FEBS LETTER, vol. 418, 1997, pages 58 - 62
J BIOL CHEM, vol. 289, 2014, pages 35826 - 35838
See also references of EP 3769762A4
Attorney, Agent or Firm:
NAKAJIMA, Jun et al. (JP)
Download PDF: